In this context, Noxa antagonizes the function of Mcl-1, and therefore high levels of Noxa render cancer cells susceptible to BH3 mimetics, such as ABT263 and ABT199, also known as navitoclax and venetoclax, respectively (14–16). This evidence concerns the gene MCL1 and cancer.